Fujian Shengdi Pharmaceuticals

Fujian Shengdi Pharmaceuticals is a prominent subsidiary of Jiangsu Hengrui Pharmaceuticals, one of China's leading innovative pharmaceutical companies. Established in 2017 and located in Fuzhou, the company serves as a critical research, development, and manufacturing hub within Hengrui's global network. It focuses on the production of high-end innovative drugs, including small molecules and biologics, across therapeutic areas such as oncology, metabolic diseases, and autoimmune disorders. The facility is designed to meet international GMP standards, supporting the commercialization of Hengrui's extensive pipeline for both domestic and global markets. As a key component of Hengrui's strategic expansion, Fujian Shengdi plays a vital role in advancing the parent company's mission to provide affordable, high-quality medicine.